Systemic Delivery Strategies for Oncolytic Viruses: Advancing Targeted and Efficient Tumor Therapy

Area of Science:

• Oncology
• Virology
• Immunology

Background:

• Oncolytic viruses (OVs) offer selective tumor cell replication and stimulate antitumor immune responses.
• Effective delivery of OVs to solid tumors, particularly internal ones, remains a significant hurdle.
• Intravenous delivery is promising but faces challenges like premature clearance by immune components.

Purpose of the Study:

• To review and discuss promising delivery methods for oncolytic viruses (OVs).
• To address the challenge of protecting systemically delivered OVs from the bloodstream's neutralizing environment.
• To highlight strategies for enhancing OV efficacy in reaching tumor sites.

Main Methods:

• Literature review of current preclinical and clinical investigations.
• Analysis of various strategies for shielding oncolytic viruses during systemic administration.
• Discussion of methods aimed at improving tumor targeting and retention of OVs.

Main Results:

• Several innovative delivery strategies are under investigation to overcome bloodstream barriers.
• Methods focus on protecting viral integrity and function from immune clearance.
• Optimizing delivery enhances the potential for effective tumor site accumulation.

Conclusions:

• Developing robust delivery systems is crucial for realizing the full therapeutic potential of oncolytic viruses.
• Protecting OVs from premature clearance is essential for successful intravenous cancer therapy.
• Further research into advanced delivery methods will improve oncolytic virotherapy outcomes.